Professor Macfarlane focuses on patient diagnosis and initiation of management, collaborating with General Practitioners to transfer care to GPs. He is Head of Clinical Services, The Dementia Centre, HammondCare, Melbourne AU. He coordinates a specialist clinical support team while applying his 20 years’ experience in running Phase II-III Alzheimer’s disease clinical trials as a Principal […]
Read More
Dr. Borad received his MD from Rutgers New Jersey Medical School, completed internal medicine training at Cedars-Sinai, medical oncology training at Tulane University, and was a Genomics Medicine and Drug Development Scholar at TGen under the tutelage of Dr. Daniel Von Hoff. His team was the first to demonstrate anti-tumor activity in FGFR2-fusion cholangiocarcinomas using […]
Read More
Graham holds a PhD in Neuropharmacology from the University of Edinburgh Medical School. His more than 30 years of industry experience includes clinical operations, project management, regulatory consulting and business development. Formerly VP, Clinical Development, Travecta Therapeutics, Graham has also held senior management roles in UK and Singapore with Parexel, ICON, Quintiles and Syneos. He […]
Read More
Susan is responsible for U.S. project and clinical operations, including project management, study startup, monitoring and site management services. With over 25 years in clinical research, she brings experience in all phases of clinical trials, multiple therapeutic areas including over 12 years in oncology, and key leadership roles in clinical operations and financial management. She […]
Read More
Dr. Hettiarachchi specializes in clinical trial operational strategy for recruitment, retention and successful trial delivery. An experienced clinical trial specialist, he has nearly three decades of clinical research experience in academic research, CROs, Pharma and biotech. He has managed many global clinical trials from start-up to CSR in various therapeutic areas, specializing in pivotal renal […]
Read More
Gillian specializes in early phase clinical trial management and developing productive relationships with key opinion leaders. With more than 20 years of experience in the pharmaceutical industry and contract research organizations, she has worked in all phases of drug development and across multiple therapeutic areas. She is experienced in local and international quality and technical […]
Read More
Dr. Pascual focuses on clinical immunosuppression and kidney transplantation in elderly and frail renal patients. He is Medical Director, Hospital Universitario 12 de Octubre, Madrid. Since 1995, he has managed the hospitalization unit within the Kidney Transplantation Program at Hospital Ramon y Cajal and has had a very active role in the development of new […]
Read More
Dr. Noronha focuses on the study of the cellular and molecular mechanisms involved in kidney fibrogenesis and the progression of renal diseases in several experimental models of CKD. She is full professor of Nephrology, University of Sao Paulo Medical School, and Head, Renal Division, Hospital das Clinicas, University of Sao Paulo Medical School. She has […]
Read More
Dr. Cheung’s clinical and research interests focus on glomerular diseases, especially IgA nephropathy, vasculitis, lupus nephritis and CKD. He is a Consultant Nephrologist and Honorary Senior Lecturer, University of Leicester, UK. He leads a number of investigator-initiated studies in IgAN, and has served as UK national chief investigator and principal investigator on multiple clinical trials. […]
Read More
Dr. Khasraw’s research focuses on the development and design of innovative clinical trials to improve patient outcomes of primary and metastatic cancers of the central nervous systems. He is a neuro-oncologist, professor of medicine and Deputy Director of the Center for Cancer Immunotherapy at Duke where he is tasked with speeding up translation for scientists […]
Read More
Professor Thomas’ research focus is on the application of genomic technologies to the understanding and management of cancer. He is the inaugural Director, Centre for Molecular Oncology, University of New South Wales; Head of the Genomic Cancer Medicine Laboratory, Garvan Institute of Medical Research; and CEO of Omico. He founded the Australasian Sarcoma Study Group […]
Read More
Dr. de Ferris’ research focus is on healthcare transitions and increasing autonomy for children with chronic kidney disease as they move from childhood to adulthood. She is Professor, UNC School of Medicine, Dept. of Pediatrics and Director, UNC Transition and Self-Management Program. Her clinical practice is in pediatric nephrology. Dr. de Ferris is also the […]
Read More
Dr. Trimarchi’s research focuses on glomerular diseases, particularly in proteinuria and podocyturia, IgA nephropathy, focal and segmental glomerulosclerosis and Fabry disease, in the endothelium in renal replacement therapies. He is Head of the Division of Nephrology and Renal Transplantation at the Hospital Británico de Buenos Aires and a member of the Steering Committee of the […]
Read More
Graham holds a PhD in Neuropharmacology from the University of Edinburgh Medical School. His more than 30 years of industry experience includes clinical operations, project management, regulatory consulting and business development. Formerly VP, Clinical Development, Travecta Therapeutics, Graham has also held senior management roles in UK and Singapore with Parexel, ICON, Quintiles and Syneos. He […]
Read More
Dr. Wabnitz has extensive experience in clinical development with a unique combination of clinical medicine, pharmacology, toxicology and industry drug development experience. He is Consultant Physician at Royal Adelaide Hospital (FRACP), Australia. He has acted as an investigator and Medical Monitor in over 50 first in human Phase I/II clinical trials as well as previously […]
Read More
Dr. Kotwal is a clinical nephrologist at Prince of Wales Hospital in Sydney Australia, Program Head of the Renal and Metabolic Division at The George Institute for Global Health and a senior clinical lecturer at the University of NSW. She is the principal investigator for the Glomerular Disease Registry and Biobank in Sydney and the […]
Read More
Ms. Hones is responsible for strategically advising and overseeing the effective delivery of George Clinical’s portfolio of kidney and metabolic clinical trials. She has extensive experience in leading teams in global studies including a program of large multi-national kidney and metabolic outcomes trial. Her nearly 20 years of clinical trial experience in the pharmaceutical, academic […]
Read More
Matthew leads Business Development in the USA and Europe, managing a team with responsibility for growing the number of sponsors we work with along with increasing sales for the USA and EU. Matthew came to George Clinical with strong leadership and management skills and 20 years of experience with multinational pharmaceutical companies. His broad spectrum […]
Read More
Ms. Coggan’s expertise lies in the implementation of pragmatic randomized clinical trials, data linkage, building collaborative relationships with commercial and academic sponsors and implementing corporate knowledge within future renal research activities. She is a Senior Project Manager at George Clinical as well as at The George Institute for Global Health. She has completed a Bachelor […]
Read More
Glenn Kerkhof is Non-Executive Director of George Clinical. Glenn has over 27 years’ experience in the contract research or drug development industry and joined George Clinical from Chiltern, where he was Chief Executive Officer. Before Chiltern, Glenn served as Vice President, Clinical Services for Charles River Laboratories, and as Vice President, Clinical Europe for Inveresk […]
Read More
James Cheong is Chief Executive Officer of George Clinical. James has significant business leadership experience and more than 20 years of industry experience in both global pharma and CRO companies in the areas of Clinical Operations, Regulatory Affairs, Data Science and Regional Management. Prior to George Clinical, Cheong served as Head of Clinical Operations for […]
Read More
Scott is the Chief Financial Officer & Director, Corporate Development for George Health Enterprises, the company that holds George Clinical. Scott was formerly the Global Health Sector Lead and a Principal Investment Officer for the International Finance Corporation, the private sector arm of the World Bank Group. During his time at IFC, Scott led numerous […]
Read More
Matthew is the Chief Financial Office for George Clinical. He was formerly the Chief Financial Officer for global IVF service provider Virtus Health and prior to this, Vice President, Finance & Commercial Operations, Asia Pacific for Cochlear. He previously served as the Head of Equities Research at Evans & Partners and Head of Healthcare Equities […]
Read More
As Chief Business Office for George Clinical, Sean Hart leads the U.S. and Asia-Pacific business development teams and directs global marketing and public relations efforts for George Clinical. Prior to joining George Clinical, Sean was the Executive Vice President and Managing Director of Vector Oncology overseeing the Global Pharma Services team including early phase and […]
Read More
Maria serves as the Chief Medical Officer for George Clinical, responsible for continuing to build the organization’s enviable network of investigators and scientific leaders. Previously, she led the medical and safety services group at George Clinical who provide safety management, endpoint adjudication, medical monitoring and scientific leadership for both commercially sponsored and academic clinical trials. […]
Read More
Jacqueline is responsible for global corporate and commercial functions which includes oversight of legal and contracting activities, insurance, risk management, corporate compliance, knowledge management and external vendor solutions. Jacqueline is also responsible for oversight of the offices in Asia and Europe and Country Head for Australia and New Zealand. Jacqueline has extensive experience in business […]
Read More
Jing Ping oversees operational delivery for studies conducted in Asia Pacific and heads the project operations group. She also provides oversight to key accounts at governance levels. With almost three decades of leadership and management experience, she has overseen all aspects of a startup’s operations in Asia Pacific and led a global biopharmaceutical unit with […]
Read More
Graham holds a PhD in Neuropharmacology from the University of Edinburgh Medical School. His more than 30 years of industry experience includes clinical operations, project management, regulatory consulting and business development. Formerly VP, Clinical Development, Travecta Therapeutics, Graham has also held senior management roles in UK and Singapore with Parexel, ICON, Quintiles and Syneos. He […]
Read More
As Country Head and Regional Head of Project Operations, China, Zhenfei is responsible for leading the operations teams across China. Zhenfei Yin brings with him more than 14 years of substantial industry experience leading Clinical Operations, Project Management, and Business Development teams across the CRO and Pharmaceutical sectors, including experience in Electronic Data Capture trials. […]
Read More
Research focused on clinical and epidemiological aspects of stroke, cardiovascular disease and aged care. Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney, and in clinical practice at Royal Prince Alfred Hospital, Sydney. Executive Director of The George Institute for Global Health, China at Peking University Health Science Center, Beijing. Senior Investigator Fellow of […]
Read More
Amanda is responsible for the project management and clinical operations teams to deliver George Clinical’s studies to the highest standards. Amanda has over 25 years’ experience implementing clinical trials across the Asia-Pacific region and more than 20 years’ line management experience. Amanda has worked across all clinical trial phases and George Clinical’s therapy areas. Her […]
Read More
Abby Abraham serves as the Global Head of Data Science for George Clinical. Abby is responsible for developing new capabilities in data science and operations and enabling continued growth of Data management in the organization. He brings a combination of significant experience in clinical operations, leveraging data for operational effectiveness, and adopting new technologies to […]
Read More
Louise Brnabic, Global Head, Quality, and is responsible for providing quality management support for all functional areas and countries, ensuring that global standards are maintained in all clinical trial-related activities. With a background in biochemical research, Louise has 20 years’ experience in quality management, project management, and clinical operations. She has worked with pharmaceutical and […]
Read More
Harmony leads the Human Resources (HR) team globally to effectively partner with the organization to deliver on its people and company objectives. Harmony has over 15 years of talent acquisition and generalist HR experience across the Life Sciences, IT&T and Built Environment industries globally and is MBA qualified in addition to holding a BA (Organizational […]
Read More
Professor Heerspink’s principal research interests include optimizing current treatment strategies and finding new therapeutic approaches to halt the progression of renal and cardiovascular disease in patients with diabetes with a specific focus on personalized medicine. He is Professor of Clinical Trials and Personalized Medicine; Clinical Pharmacologist at the Department of Clinical Pharmacy and Pharmacology at […]
Read More
Professor Gallagher’s research interests include large scale clinical trials exploring ways to improve outcomes of kidney patients with a focus on acute kidney injury, long term treatment effects, and applying research evidence into practice. He is Associate Professor, Faculty of Medicine, UNSW, Sydney; Director of the Renal and Metabolic Division in The George Institute for […]
Read More
Professor Barratt’s research is focused on pathogenesis of IgA nephropathy and a range of areas across renal medicine including glomerular disease, multi-system renal disease and complications of chronic kidney disease, in particular renal associated anaemia. He is the IgA nephropathy Rare Disease Group lead for the UK National Registry of Rare Kidney Diseases and leads […]
Read More
Dr. Jha’s research is focused on understanding the health and societal impact of kidney diseases globally and developing affordable, scalable and sustainable primary and secondary prevention tools. He is Executive Director, The George Institute for Global Health, India; President of the International Society of Nephrology; and Chair of Global Kidney Health, Faculty of Medicine, Imperial College […]
Read More
Dr. Liew’s research interests include glomerular diseases, peritoneal dialysis and diabetic kidney disease. He is a member of the Executive Committee of the ISN and chairs the ISN Oceania-Southeast Asia Regional Board. He serves as Senior Consultant Nephrologist and Director of The Kidney and Transplant Practice at Mount Elizabeth Novena Hospital, Singapore, and is a […]
Read More
Dr. Pecoits-Filho’s research is focused on chronic kidney disease and he is currently a Visiting Researcher at The George Institute for Global Health, Sydney. He was a member of the Executive Committee of KDIGO and the International Society of Nephrology (ISN) and is currently the chair of the ISN Education Working Group, and part of […]
Read More
Dr. Wong’s research interest is in understanding the pathomechanism of kidney fibrosis and he has actively promoted the development of both clinical and pre-clinical research in delaying CKD progression in diabetic nephropathy, IgA nephropathy, and management of cardiovascular complications associated with CKD. He is a renal physician and Senior Staff Specialist at the Royal North […]
Read More
Staph is the President and Chief Executive Officer of George Health Enterprises. Previously, Staph was President and Chief Operating Officer of the Clinton Health Access Initiative (CHAI). Staph has close to 30 years of senior executive and board-level experience, leading, growing, and transforming global pharmaceutical, biotechnology and not-for profit organisations, from start-ups to large, complex […]
Read More
Dr. Wheeler’s research interests are in chronic kidney disease complications, specifically those that increase cardiovascular disease burden and/or accelerate kidney failure progression. He is Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust and Professor of Kidney Medicine at University College London. He has participated in developing and running several large-scale clinical trials […]
Read More
Professor Perkovic’s research is focused on clinical trials and epidemiology, including the prevention of progression and complications of kidney disease. He is Chair of the International Society of Nephrology Action for Clinical Trials group; Dean of Medicine and Scientia Professor at UNSW; and Professorial Fellow at The George Institute for Global Health. He also serves as […]
Read More
Jean Edwards has over 30 years of experience working within the global pharmaceutical industry. In her last role Jean led clinical trial outsourcing and procurement at Eli Lilly for Europe, Australia and Japan. Jean was also the COO for Chorus Europe at Eli Lilly. Prior to that Jean worked across various roles at Bayer from […]
Read More
Dr. Schwartzberg’s research interests focus on breast cancer, supportive care, precision medicine and patient reported outcomes. He is Chief, Medical Oncology and Hematology at the at the William N. Pennington Cancer Institute at Renown Health and Professor of Clinical Medicine, University of Nevada School of Medicine Reno. He has published over 300 peer reviewed manuscripts, […]
Read More
Dr. Boccia focuses on cutting-edge drug development. He is Medical Director of the Center for Cancer and Blood Disorders in Bethesda, Maryland, where he has up to 60 clinical trials at all times, and 10 FTEs for research. He is also Clinical Associate Professor of Medicine at Georgetown University in Washington, DC. and serves as […]
Read More
Dr Jeremy Teoh’s research interests are in bladder and prostate cancer including urinary biomarkers for bladder cancer and androgen deprivation therapy for prostate cancer. He is Assistant Dean (External Affairs) and Assistant Professor of the Faculty of medicine, The Chinese University of Hong Kong. He is also Chairperson of the Younger Fellows Chapter of the […]
Read More
Dr. VanderWalde specializes in melanoma and is experienced in genomic tumor assessment, public health, tumor immunotherapy, medical ethics and precision oncology. He is the Global Head of Clinical Research at Caris Life Sciences and works as Research Faculty at West Cancer Center where he served as the Director of Research from 2014 to 2021. He […]
Read More
Dr. Loong’s research focuses on sarcoma medical oncology, neuro-oncology, thoracic oncology and experimental therapeutics (Phase I trials). Based in Hong Kong, he holds conjoint appointments of Clinical Associate Professor, Department of Clinical Oncology and Deputy Medical Director, Phase I Clinical Trials Centre, The Chinese University of Hong Kong. He is the current and founding convenor, […]
Read More
Dr. Pluard’s research focuses on novel therapies in metastatic breast cancer. He is Medical Director at Luke’s Cancer Institute and Founding Director of Saint Luke’s Koontz Center for Advanced Breast Cancer, Kansas City. Previously, he was Associate Professor of Medicine and Clinical Director of Breast Oncology at Washington University Siteman Cancer Center, St. Louis. His […]
Read More
Dr. Chandler focuses on blood cancers with a specific focus of cellular therapy in multiple myeloma and lymphoma. He heads up malignant hematology research at West Cancer Center in Memphis, TN. He spent five years as a member of the NCCN guidelines committee for multiple myeloma and is involved in multiple clinical trials ranging from […]
Read More
Dr. Kosiborod’s research has a strong focus on the intersection of diabetes and cardiovascular disease. He is Vice President of Research at Saint Luke’s Health System; Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute; and Professor of Medicine at the University of Missouri-Kansas […]
Read More
Research interests include the environmental determinants of chronic disease and the potential for changes in the food supply to deliver large, cost-effective and equitable health gains. Founding member and Executive Director, The George Institute for Global Health; Professor of Medicine, UNSW Sydney; and Professor of Clinical Epidemiology at Imperial College London. Expertise in the management […]
Read More
Professor Rodgers’ principal focus is on cardiovascular disease prevention, innovation and public-private partnerships, and in scaleable interventions to address major health risks. He is Professor of Global Health at The George Institute for Global Health and Chair of Clinical Epidemiology, Imperial College London. He was the principal author of the 2002 World Health Report, the […]
Read More
Dr. Sundström’s research focuses on causes and consequences of hypertension. He is Professor of Epidemiology at Uppsala University; Conjoint Professor at The George Institute for Global Health, University of New South Wales; and a clinical specialist in the internal medicine and cardiology at Department of Cardiology, Uppsala University Hospital. He also heads the university’s Clinical […]
Read More
Professor Chalmers’ research interests include large scale clinical trials and epidemiological studies related to hypertension, coronary heart disease and stroke, and diabetes and renal disease. He is Senior Director, Professorial Unit, The George Institute for Global Health and Professor of Medicine, UNSW Sydney, as well as Emeritus Professor of Medicine at Flinders University and at […]
Read More
Dr. Delcourt’s research interests are stroke, health systems, clinical trials and epidemiology. She is Senior Research Fellow at The George Institute for Global Health and the Hunter Stroke Service in Newcastle, and Senior Clinical Lecturer at the University of Sydney. She has extensive experience in the design, management, conduct and reporting of clinical trials and […]
Read More
Dr. Jenkins’ research is focused on the clinical management of airways disease and patient reported outcomes in response to therapeutic interventions. She is Head of the Respiratory Group at The George Institute for Global Health; Senior Staff Specialist in Thoracic Medicine at Concord Hospital, Sydney; Clinical Professor and Head of Respiratory Discipline at University of Sydney; and Professor […]
Read More
Jessie is responsible for leading the East Asia project management and clinical operations teams across East Asia countries including Hong Kong, Malaysia, South Korea, Taiwan, Thailand, Indonesia, Vietnam, and Philippines. She has over 15 years’ experience working in the pharmaceutical and clinical research industry in various fields including project management and global studies. In addition, […]
Read More
